ST. PETERSBURG, Fla. — In a decisive move against a potent substance derived from the kratom plant, Florida officials, along with federal authorities, have initiated an emergency ban on 7-OH, a compound linked to multiple fatalities in the state. This substance, which possesses opioid-like properties, has raised significant alarm among public health officials.
Florida Attorney General James Uthmeier announced the emergency measures during a press conference, emphasizing the need for immediate action. “We are taking steps to classify 7-OH as a Schedule One drug, which reflects its seriousness and potential for abuse,” he stated, underscoring the urgency of the situation.
Extracted from kratom leaves found in Southeast Asia, 7-OH is not to be confused with the natural plant itself. Experts warn that this concentrated byproduct can be remarkably more powerful, sometimes touted as being up to 13 times more potent than morphine. “Consider the ramifications of a teenager consuming a gummy bear that’s that strong,” remarked Charles J. Lockwood, Executive Vice President of USF Health, illuminating the product’s danger.
The substance has been marketed in various forms — from flavored gummy candies to tablets and even wellness shots — making it more appealing and accessible, especially to younger audiences. Uthmeier noted that while kratom products are often promoted in smoke shops, this crackdown specifically targets the enhanced and more hazardous variant of the substance. “This is not a ban on all kratom,” he clarified. “Our focus is on this highly chemically modified product.”
The swift action reflects a broader lesson learned from previous public health crises involving substances like fentanyl and other prescription drugs. “We cannot afford to find ourselves in another scenario where we are addressing an emerging crisis too late,” said FDA Commissioner Dr. Marty Makary, adding urgency to the message of prevention.
The emergency ban took effect immediately, with the FDA requiring retailers to withdraw 7-OH from their inventories without delay. Enforcement actions could commence as early as Thursday, signaling a proactive approach to ensure the safety of the public.
As states increasingly grapple with the complexities of substance regulation and public health, this decisive action highlights a growing awareness among authorities of the potential dangers posed by newer, unregulated compounds.